The early response of infant mice to foot-and-mouth disease viral antigens, measured by greater resistance and increased serum-neutralizing antibody, was enhanced by divinyl ether-maleic anhydride (DVE/MA). Preparations of known antigen concentration were used to study various parameters influencing this enhancement. Resistance and antibody levels were increased when DVE/MA was administered with aqueous or oil-emulsified antigens, whether given separately or mixed with the antigens, but was dependent on the dose and route of the DVE/MA and antigen. Enhanced resistance developed rapidly, was antigenspecific, and may have been related to the level of neutralizing antibody.
Divinyl ether-maleic anhydride (DVE/MA or pyran copolymer) is one of many polyanions that stimulate nonspecific antiviral activity in experimental animals. Interferon induction, antitumor activity, adjuvant activity, and altered reticuloendothelial system response have all been shown after DVE/MA administration (5, 14, 16, 17, 19) , although the mode of action of the polymer is still unknown (1, 15) .
In previous studies, a dose of 120 mg of DVE/MA per kg protected infant mice against the lethal effects of foot-and-mouth disease (FMD) virus (20) , perhaps due to inhibition of virus multiplication in vivo (21) . More recently, we reported (7) (7) .
In most studies of polyanion adjuvanting effects, sheep erythrocytes have been used as antigens; this system allows for detailed analysis of both the primary and secondary immune responses (3, 8, 11, 14, 15, 17) . Data have been presented to indicate polyanionic stimulation of both B-cells (10) and T-cells (9) . In studies reported here, concentrated or purified viral antigens, various injections procedures, and aqueous as well as oil-emulsified antigens were used to evaluate the stimulating effect of DVE/ MA on induced resistance and early antibody formation in a mouse model system. Experimental application of these findings in a host species naturally susceptible to FMD virus will be described in a following report.
( (20) . Percentage computations were subjected to arc sine transformation before analysis, and all data were tested by analysis of variance (22) . Serum neutralization. Mice were bled by cardiac puncture under CO2 anesthesia, and sera, pooled from 10 to 20 similarly treated mice per group, were heated at 56 C for 30 min and stored at -10 C. Antibody titers were determined in mice (12) and are reported as log,0 mean protective dose values. Sera unable to protect mice at a 1:2 dilution were considered antibody negative. To determine the specificity of the antibody produced, some sera were treated with 2-mercaptoethanol (13) AAg, or with either aqueous antigen alone. At daily intervals, mice from each group were bled or injected with dilutions of corresponding virus. Figure 1 presents the observed levels of resistance and serum-neutralizing antibody ti- antibody titer only for the injected antigen. Slight cross-reactivity was observed with some of the sera collected 4 dpi. Treatment of these sera with 2-mercaptoethanol removed the neutralizing activity of' the early samples but not of the sera collected 28 dpi. DISCUSSION This mouse model system for investigating antiviral enhancing effects of polyanions was developed because our concern has been related primarily to animal resistance against a specific virus (20, 21) . The data presented here indicated that mice of the age used could produce serumneutralizing antibody in response to injections of at least 0.5 jug of OAg. It was furthermore indicated that the oil emulsion was not necessary to show increased resistance when DVE/ MA was administered with the antigen (Table   1 ).
The possibility of an interferon-mediated resistance against FMD virus after DVE/MA administration has been considered minimal due to the transient nature and low titers of the interferon response (20) . Mechanisms other than an interferon response have been suggested to interpret DVE/MA-mediated resistance (1, 14, 15) . However, cells of the reticuloendothelial system clearly are involved (19) . DVE/MA appears to express its biological activity when administered in the vicinity of peritoneal cells ( Table 2) . Part of this induced antiviral resistance may be related to inhibited virus release from the peritoneal cavity as suggested for another polycarboxylate, chlorite-oxidize oxyamylose (1). It should be noted that levels of DVE/MA too low to induce resistance when given alone stimulate both an antiviral state and increased antibody production when given with the antigen (Table 3) .
The levels of resistance and serum-neutralizing antibody seen after administration of DVE/ MA and 0.015 jig of aqueous FMD antigen were comparable with those seen after administration of 0.25 jg of AAg alone (Table 4 ). This comparability suggests that DVE/MA altered the host's ability to respond to very low antigenic stimulation. Braun has proposed (2-4) that the polyanionic nature of these compounds stimulates the function of primary antigen-handling cells; additional effects on the macrophages or other cells involved with the immune response may be due to cytotoxicallv released oligonucleotides.
Measured in terms of resistance and neutralizing antibody, mouse response to the O1Br antigen was markedly better than the response to the OCas antigen (Fig. 1 
